Novavax
$179.229876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$179.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$16.74 (+10.59%) Today
+$4.38 (+2.51%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Novavax and other stocks, options, and ETFs commission-free!
About NVAX
Novavax, Inc. Common Stock, also called Novavax, is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. The firm's vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD. The listed name for NVAX is Novavax, Inc. Common Stock.
CEO
Stanley C. Erck
Employees
791
Headquarters
Gaithersburg, Maryland
Founded
1987
Market Cap
15.00B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.90M
High Today
$175.89
Low Today
$149.12
Open Price
$166.65
Volume
5.83M
52 Week High
$331.68
52 Week Low
$6.77
NVAX News
MarketWatchMar 5
Novavax Inc. stock rises Friday, outperforms market
Shares of Novavax Inc. NVAX, +10.59% jumped 10.59% to $174.84 Friday, on what proved to be an all-around great trading session for the stock market, with the NA
Analyst Ratings
83%
of 6 ratings
Buy
83%
Hold
17%
Sell
0%
NVAX Earnings
-$3.21
-$1.56
$0.08
$1.73
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$1.49 per share
Actual
-$2.70 per share
